Literature DB >> 1351928

Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.

R Bertorelli1, M Zambelli, G Di Chiara, S Consolo.   

Abstract

The roles of D2 and D1 dopaminergic receptors on the regulation of striatal acetylcholine (ACh) release in vivo were examined for a period of 120 min after acute (2 h) or prolonged (16 h) depletion of brain dopamine (DA) by alpha-methyl-p-tyrosine. The reduction of DA transmission did not affect basal ACh output after 2 h but markedly lowered ACh release by 16 h (50%). Acute alpha-methyl-p-tyrosine pretreatment prevented the reduction of ACh release by the D1 antagonist SCH 23390 and its increase by the D2 antagonist, remoxipride, consistent with a drastic reduction of DA transmission at both DA receptors. However, 16 h after alpha-methyl-p-tyrosine, the effect of remoxipride on ACh release was restored, but SCH 23390 still had no effect, suggesting that the D2 inhibitory tone on ACh release had recovered, whereas the reduction of the D1 facilitatory influence persisted. The D1 facilitatory control of ACh neurotransmission thus appears to be more sensitive than the D2 inhibitory control to a reduction in DA transmission. The new model of DA-ACh interaction resulting from these data casts fresh light on the relationship between changes in DA transmission and extrapyramidal motor function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351928     DOI: 10.1111/j.1471-4159.1992.tb08911.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

2.  Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Authors:  Yoko Hagino; Shinya Kasai; Masayo Fujita; Susumu Setogawa; Hiroshi Yamaura; Dai Yanagihara; Makoto Hashimoto; Kazuto Kobayashi; Herbert Y Meltzer; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.